Clinical Trial Update: Rivaroxaban or Aspirin for Biological Aortic Prosthesis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rivaroxaban versus aspirin for patients with biological aortic valve prostheses; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Regurgitation
• Aortic Stenosis
• Thrombosis

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Christian Torp-Pedersen | Conditions: Aortic Stenosis, Aortic Regurgitation | Phase 4 | Status: UNKNOWN